Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Fate Therapeutics Inc

NASDAQ: FATE · Life Sciences · 4 alerts · CIK 1434316

Share price
$1.14Close, Nov 16
Market cap
$139M
Shares outstanding
121.57MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Fate Therapeutics Inc filings on SEC EDGAR ↗

4:01 PM ET Form 4
Insider Selling

Fate Therapeutics CFO Kamal Adawi Sells $13.5K of Stock

Kamal Adawi, CFO, sold 6,582 shares of Fate Therapeutics Inc at $2.05 a share, worth $13.5K in total on Nov 3, 2026. Shares held after the trade: 93,418 (-6.6%).

Value
$13.5K
Shares
6,582
Price
$2.05
Role
CFO
Holding change
-6.6%
Trade date
Nov 3, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.